Beranda › Histiositosis Sel Langerhans › Texas
Uji klinis Histiositosis Sel Langerhans di Texas
4 studi untuk Histiositosis Sel Langerhans mencari peserta di lokasi di Texas.
Kota di Texas
Teks studi resmi (Bahasa Inggris)
A Study With Tovorafenib (DAY101) as a Treatment Option for Progressive, Relapsed, or Refractory Langerhans Cell Histiocytosis
- Dell Children's Medical Center of Central Texas, Austin
- UT Southwestern/Simmons Cancer Center-Dallas, Dallas
- El Paso Children's Hospital, El Paso
- dan 6 lainnya
Menerima pesertaFase 2
180 Days – 22 Years · Semua jenis kelamin · Diperbarui 2 Okt 2026 · NCT05828069Targeted Approach to Langerhans Cell Histiocytosis (LCH) Using MEK Inhibitor, Trametinib
- Cook Children's Health Care System, Fort Worth
Menerima pesertaFase 2
Usia 1 hingga 30 · Semua jenis kelamin · Diperbarui 7 Apr 2026 · NCT06582745Cobimetinib in Refractory Langerhans Cell Histiocytosis (LCH), and Other Histiocytic Disorders
- Children's Medical Center- UTSW, Dallas
- Texas Children's Hospital, Houston
Menerima pesertaFase 2
Semua usia · Semua jenis kelamin · Diperbarui 18 Sep 2025 · NCT04079179Vinblastine/Prednisone Versus Single Therapy With Cytarabine for Langerhans Cell Histiocytosis (LCH)
- Dell Children's Medical Center, Austin
- Cook Children's Health Care System, Fort Worth
- Texas Children's Hospital, Houston
- dan 2 lainnya
Menerima pesertaFase 3
Hingga usia 21 · Semua jenis kelamin · Diperbarui 11 Sep 2025 · NCT02670707Dari ClinicalTrials.gov, data diambil 5 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.